1[1]Ring J, Darsow U, Behrendt H. Atopic eczema and allergy[J].Curr Allergy Rep, 2001, 1(1): 39-43.
2[2]Sderhll C, Bradley M, Kockum I, et al. Linkage and associationto candidate regions in Swedish atopic dermatitis families[J]. Hum Genet, 2001,109(2):129-135.
3[3]Finlay AY. Measurement of disease activity and outcome in atopic dermatitis[J]. Br J Dermatol, 1996, 135(4): 509-515.
5[5]Lebwohl M, Heymann WR, Berth-Jones J, et al. Treatment of Skin Disease: Comprehensive Therapeutic Strategies[M]. London: Harcourt Publishers Limited, 2002. 58-64.
6Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy, 2001, 56:1034-1041.
7Thienpont D, Van Cutsem J, Van Nueten JM, et al. Biological and toxicological properties of econazole, a broad-spectrum antimycotic.Arzneimittelforschung, 1975, 25: 224-230.
8Strippqli V, D'Auria FD, Simonetti N. In vitro antimicrobial activity of econazole and miconazole sulfosalicylate. Drugs Exp Clin Res,1990, 16: 237-242.
9Polano MK, De Vries HR. Analysis of the results obtained in the treatment of atopic dermatitis with corticosteroid and neomycin containing ointments. Dermatologica, 1960, 120:191-199.
10Ramsay C, Savoie C, Gilbert M. The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate J Eur Acad Dermatol Venereol, 1996, 7:S15-S22.
